ArticleCancers2026

Perioperative Nivolumab and Ipilimumab with Chemotherapy and Chemoradiation for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Phase 1/2 Non-Randomized Clinical Trial.

Mariela A Blum Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.